Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis

• Sheila A. Fisher,

  Affiliations Systematic Review Initiative, NHS Blood and Transplant, John Radcliffe Hospital, Oxford, United Kingdom, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Carolyn Dorée,

  Affiliations Systematic Review Initiative, NHS Blood and Transplant, John Radcliffe Hospital, Oxford, United Kingdom, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Susan J. Brunskill,

  Affiliations Systematic Review Initiative, NHS Blood and Transplant, John Radcliffe Hospital, Oxford, United Kingdom, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Anthony Mathur,

  Affiliation Queen Mary University of London CV Biomedical Research Unit, Barts and The London School of Medicine and Dentistry, London, United Kingdom

  ⨯
• Enca Martin-Rendon

  * E-mail: enca.rendon@ndcls.ox.ac.uk

  Affiliations Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom, Stem Cell Research Laboratory, NHS Blood and Transplant, John Radcliffe Hospital, Oxford, United Kingdom

  ⨯